Yang Wan Seok, Kim Katherine J, Gaschler Michael M, Patel Milesh, Shchepinov Mikhail S, Stockwell Brent R
Department of Biological Sciences, St. John's University, Queens, NY 11439;
Department of Biological Sciences, Columbia University, New York, NY 10027;
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E4966-75. doi: 10.1073/pnas.1603244113. Epub 2016 Aug 9.
Ferroptosis is form of regulated nonapoptotic cell death that is involved in diverse disease contexts. Small molecules that inhibit glutathione peroxidase 4 (GPX4), a phospholipid peroxidase, cause lethal accumulation of lipid peroxides and induce ferroptotic cell death. Although ferroptosis has been suggested to involve accumulation of reactive oxygen species (ROS) in lipid environments, the mediators and substrates of ROS generation and the pharmacological mechanism of GPX4 inhibition that generates ROS in lipid environments are unknown. We report here the mechanism of lipid peroxidation during ferroptosis, which involves phosphorylase kinase G2 (PHKG2) regulation of iron availability to lipoxygenase enzymes, which in turn drive ferroptosis through peroxidation of polyunsaturated fatty acids (PUFAs) at the bis-allylic position; indeed, pretreating cells with PUFAs containing the heavy hydrogen isotope deuterium at the site of peroxidation (D-PUFA) prevented PUFA oxidation and blocked ferroptosis. We further found that ferroptosis inducers inhibit GPX4 by covalently targeting the active site selenocysteine, leading to accumulation of PUFA hydroperoxides. In summary, we found that PUFA oxidation by lipoxygenases via a PHKG2-dependent iron pool is necessary for ferroptosis and that the covalent inhibition of the catalytic selenocysteine in Gpx4 prevents elimination of PUFA hydroperoxides; these findings suggest new strategies for controlling ferroptosis in diverse contexts.
铁死亡是一种受调控的非凋亡性细胞死亡形式,与多种疾病情况相关。抑制谷胱甘肽过氧化物酶4(GPX4,一种磷脂过氧化物酶)的小分子会导致脂质过氧化物的致命性积累,并诱导铁死亡细胞死亡。尽管有人提出铁死亡涉及活性氧(ROS)在脂质环境中的积累,但ROS产生的介质和底物以及在脂质环境中产生ROS的GPX4抑制的药理机制尚不清楚。我们在此报告铁死亡期间脂质过氧化的机制,这涉及磷酸化酶激酶G2(PHKG2)对脂氧合酶铁可用性的调节,脂氧合酶进而通过在双烯丙基位置过氧化多不饱和脂肪酸(PUFA)来驱动铁死亡;事实上,用在过氧化位点含有重氢同位素氘的PUFA(D-PUFA)预处理细胞可防止PUFA氧化并阻断铁死亡。我们进一步发现,铁死亡诱导剂通过共价靶向活性位点硒代半胱氨酸来抑制GPX4,导致PUFA氢过氧化物的积累。总之,我们发现脂氧合酶通过依赖PHKG2的铁池对PUFA的氧化是铁死亡所必需的,并且对Gpx4中催化性硒代半胱氨酸的共价抑制可防止PUFA氢过氧化物的消除;这些发现为在多种情况下控制铁死亡提出了新策略。